Results
1 -
9 of
9Turlington M; Noetzel MJ; Chun A; Bridges TM; Daniels JS; Jones C; Niswender CM; Meiler J; Conn PJ; Lindsley CW; Stauffer SR; Zhou Y; Gogliotti RD; Nguyen ED; Gregory KJ; Vinson PN; Rook JM; Gogi KK; Xiang Z.
Exploration of allosteric agonism structure-activity relationships within an acetylene series of metabotropic glutamate receptor 5 (mGlu5) positive allosteric modulators (PAMs): discovery of 5-((3-fluorophenyl)ethynyl)-N-(3-methyloxetan-3-yl)picolinamide (ML254)., Journal of medicinal chemistry Metabotropic Glutamate Receptors for New Treatments in Schizophrenia, Novel Antischizophrenia Treatments mGluR5 positive modulators both potentiate activation and restore inhibition in NMDA receptors by PKC dependent pathway, Journal of Biomedical Science Drugs to Tune Up Glutamatergic Systems: Modulators of Glutamate Metabotropic Receptors, Biochemical Approaches for Glutamatergic Neurotransmission Genetic and Pharmacological Reversibility of Phenotypes in Mouse Models of Autism Spectrum Disorder, Translational Anatomy and Cell Biology of Autism Spectrum Disorder mGlu5 Signaling: A Target for Addiction Therapeutics?, mGLU Receptors Enhancement of social novelty discrimination by positive allosteric modulators at metabotropic glutamate 5 receptors: adolescent administration prevents adult-onset deficits induced by neonatal treatment with phencyclidine, Psychopharmacology mGluR5 positive allosteric modulation and its effects on MK-801 induced set-shifting impairments in a rat operant delayed matching/non-matching-to-sample task, Psychopharmacology Orchestrated activation of mGluR5 and CB1 promotes neuroprotection, Molecular Brain